Abstracts - Society for Developmental Biology
Abstracts - Society for Developmental Biology
Abstracts - Society for Developmental Biology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
145<br />
homeodomain (HD) transcription factors like Pax2 that specify the inhibitory GABAergic lineage while suppressing HD<br />
factors like Tlx1/3 that specify the excitatory glutamatergic lineage in the dorsal spinal cord. Utilizing deep sequencing of<br />
chromatin immunoprecipitation (ChIP-seq) and gene expression profiling (RNA-seq) in Ptf1a mutant versus wildtype<br />
neural tubes, we identified Prdm13, a putative chromatin-remodeling zinc finger transcription factor, as a direct<br />
downstream target of Ptf1a <strong>for</strong> explaining how Ptf1a can suppress gene expression. Prdm13 is lost in Ptf1a domains in the<br />
Ptf1a null mouse. In both gain and loss of function experiments in chick neural tube, Prdm13 phenocopies Ptf1a by<br />
inducing Pax2 + /GABAergic neurons and suppressing the Tlx1/3 + /glutamatergic neurons. This neuronal cell-fate<br />
specification function by Prdm13 requires the zinc finger domains and transcriptional repressor activity. Epistasis<br />
experiments confirm Prdm13 functions downstream of Ptf1a, and Ptf1a requires Prdm13 <strong>for</strong> its function in neuronal<br />
specification. Furthermore, Prdm13 regulates this neuronal specification through directly repressing transcription of<br />
dI5/dILB lineage genes through DNA binding activity. This activity of Prdm13 acts antagonistically to the bHLH factor<br />
Ascl1, which at this stage directs progenitors to the Tlx1/3 glutamatergic lineage. Our findings demonstrate that Prdm13 is<br />
a novel component of a highly coordinated transcriptional network necessary to mediate the balance of inhibitory versus<br />
excitatory neurons generated in the dorsal neural tube.<br />
Program/Abstract # 439<br />
Sulfatase 1, an extracellular regulator of the motoneuron to oligodendrocyte cell fate choice in the ventral spinal<br />
cord<br />
Touahri, Yacine, toulouse, France; Escalas, Nathalie; Danesin, Cathy; Soula, Cathy (Toulouse, France)<br />
In the developing vertebrate spinal cord, oligodendrocyte precursor cells (OPCs) mainly originate from ventral neural<br />
progenitors of the pMN domain, marked by Olig2 expression. These progenitors first generate motoneurons (MNs) and<br />
switch to an OPC fate after completion of MN generation. We previously evidenced that Sulfatase 1 (Sulf1), a secreted<br />
endosulfatase, is upregulated in ventral neural progenitors immediately prior to OPC specification. Sulf1 is known to<br />
regulate the sulfation state of heparan sulfate proteoglycans (HSPGs), extracellular matrix molecules involved in regulating<br />
various signaling pathways. To assess Sulf1 function in the MN/OPC switch, we recently analyzed OPC development in<br />
mice lacking Sulf1 function. Our results clearly showed that specification of ventral OPCs is severely affected in Sulf1-/-<br />
mutant mice. Indeed, the efficiency of OPC induction is reduced, only few pMN progenitors switch to an OPC fate while<br />
they continue to generate MNs passed the normal timing of the MN/OPC switch. Moreover, using chick spinal cord<br />
explants, we showed that the deficiency in OPC production in Sulf1 loss of function is not a consequence of an early<br />
phenotype but results from the timely regulated expression of Sulf1. Finally, we bring arguments supporting that Sulf1<br />
controls the MN/OPC switch by regulating Shh activity. Our work then establish that Sulf1 is a major component of the<br />
mechanisms that cause neural progenitors of the pMN domain to stop producing neurons and switch to an OPC fate.<br />
Program/Abstract # 440<br />
Removal of Polycomb Repressive Complex 2 makes C. elegans germ cells susceptible to direct conversion into<br />
specific somatic cell types<br />
Patel, Tulsi, Genetics and Development, New York, United States; Tursun, Baris (The Berline Institute <strong>for</strong> Medical<br />
Systems <strong>Biology</strong>, Berlin, Germany); Rahe, Dylan; Hobert, Oliver (Columbia University, New York, NY, United States)<br />
How specific cell types can be directly converted into other distinct cell types is a matter of intense investigation with<br />
wide-ranging basic and biomedical implications. We have recently shown that the removal of the histone chaperone LIN-<br />
53 (called Rbbp4 and Rbbp7 in vertebrates) permits ectopically expressed, neuron-type-specific transcription factors<br />
(terminal selectors) to convert C. elegans germ cells directly into specific neuron types. How the LIN-53 protein protects<br />
the germ cell genome from being converted was unclear since histone chaperones like LIN-53 function in a number of<br />
distinct, chromatin-related processes, including nucleosome assembly, remodeling, and various types of gene activation<br />
and repression events. We show here that the function of LIN-53 in the germ cell to neuron conversion process can be<br />
phenocopied by loss of members of the histone 3 lysine 27 (H3K27) methyltransferase complex PRC2. Terminal selectorinduced<br />
germ cell to neuron conversion can not only be observed upon genome-wide loss of H3K27 in PRC2(-) animals,<br />
but also upon genome-wide redistribution of H3K27 in animals which lack the H3K36 methyltransferase MES-4.<br />
Manipulation of the H3K27 status not only permits neuronal terminal selector-dependent conversion of germ cells into<br />
neurons, but also permits hlh-1/MyoD -dependent conversion of germ cells into muscle cells, indicating the PRC2 protects<br />
the germline from the aberrant execution of multiple distinct somatic differentiation programs. Taken together, our findings<br />
demonstrate that the normally multi-step process of development from a germ cell via a zygote to a terminally<br />
differentiated somatic cell type can be shortcut by providing an appropriate terminal selector transcription factor and<br />
manipulating histone methylation patterns.